Latest BVS reports update at 2024-03-12: 202320222021
Bioventus  logo

Bioventus BVS

$ 3.97 0.25%

Country

usaUSA

IPO year

2021

Industry

Diagnostics research

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Henry C. Tung

Employees in the company

-

Shares

62.6 M

Market Cap[1]

$ 249 M

EBITDA (LTM)

$ -186 M

P/E (LTM)

-0.86

P/S (LTM)

0.43

EPS (LTM)

-4.18

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.